Ashley M Nelson
Overview
Explore the profile of Ashley M Nelson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
450
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Johnson P, Woyach J, Ulrich A, Marcotte V, Nipp R, Lage D, et al.
J Geriatr Oncol
. 2023 Jun;
14(6):101538.
PMID: 37329769
Introduction: Chronic lymphocytic leukemia (CLL) commonly affects older adults. However, few studies have examined the relationship between baseline geriatric domains and clinical outcomes in this population. Here, we aim to...
12.
Nelson A, Erdmann A, Coe C, Juckett M, Morris K, Knight J, et al.
Brain Behav Immun
. 2023 May;
112:11-17.
PMID: 37236325
Increased synthesis and release of inflammatory signalling proteins is common among individuals with hematologic malignancies undergoing hematopoietic cell transplantation (HCT) due to intensive conditioning regimens and complications such as graft-versus-host-disease...
13.
Hyland K, Eisel S, Hoogland A, Root J, Bowles K, James B, et al.
Leuk Lymphoma
. 2022 Dec;
64(2):415-423.
PMID: 36476293
This controlled comparison study evaluated objective and subjective cognitive function and their relationships with patient-reported symptoms (depression, fatigue, insomnia) in patients receiving tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia...
14.
Dhawale T, Johnson P, Gaballa M, Nelson A, Lavoie M, Boateng K, et al.
Cancer
. 2022 Dec;
129(3):441-449.
PMID: 36457279
Background: Chimeric antigen receptor (CAR) T-cell is potentially curative therapy for patients with hematologic malignancies but can cause life-threatening toxicities. Data on perceptions of prognosis and psychological distress are lacking....
15.
Amonoo H, Johnson P, Nelson A, Clay M, Daskalakis E, Newcomb R, et al.
Blood Adv
. 2022 Nov;
7(7):1108-1116.
PMID: 36398978
Caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT) must cope with substantial caregiving burden, high rates of psychological distress, and diminished quality of life (QOL). However,...
16.
Amonoo H, Daskalakis E, Deary E, Bodd M, Reynolds M, Nelson A, et al.
J Natl Compr Canc Netw
. 2022 Oct;
20(10):1116-1123.
PMID: 36240844
Background: Patients with acute myeloid leukemia (AML) face an abrupt life-threatening illness and experience immense physical and psychological symptoms. However, no data describe how patients with AML cope longitudinally with...
17.
Sattur M, Nelson A, Al Kasab S, Spiotta A
Oper Neurosurg (Hagerstown)
. 2022 Aug;
23(3):250-253.
PMID: 35972089
Background: The large size of guide catheters in the traditional triaxial configuration can prove limiting during transradial vertebrobasilar thrombectomy. This is especially important for the direct aspiration technique because of...
18.
Knight J, Taylor M, Rentscher K, Henley E, Uttley H, Nelson A, et al.
Front Immunol
. 2022 Jul;
13:877558.
PMID: 35865530
A growing body of literature has emphasized the importance of biobehavioral processes - defined as the interaction of behavior, psychology, socioenvironmental factors, and biological processes - for clinical outcomes among...
19.
Amonoo H, Deary E, Harnedy L, Daskalakis E, Goldschen L, Desir M, et al.
Transplant Cell Ther
. 2022 May;
28(7):400.e1-400.e6.
PMID: 35577321
Social support is essential to the recovery of patients who have undergone hematopoietic stem cell transplantation (HSCT). We undertook a qualitative study to explore the specific sources and benefits of...
20.
Hoogland A, Barata A, Logue J, Kommalapati A, Hyland K, Nelson A, et al.
Transplant Cell Ther
. 2022 Apr;
28(6):305.e1-305.e9.
PMID: 35378330
The success of chimeric antigen receptor (CAR) T cell therapy in treating patients with relapsed/refractory hematologic malignancies is leading to a growing number of survivors treated with this regimen. To...